Page last updated: 2024-11-05

tolnaftate and Chronic Disease

tolnaftate has been researched along with Chronic Disease in 2 studies

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research Excerpts

ExcerptRelevanceReference
"Primary: to compare one-off administration of boric acid powder with courses of 1% acetic acid and ciprofloxacin eardrops in treating active chronic otitis media."5.16A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings. ( Loock, JW, 2012)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Loock, JW1
Török, I1

Trials

1 trial available for tolnaftate and Chronic Disease

ArticleYear
A randomised controlled trial of active chronic otitis media comparing courses of eardrops versus one-off topical treatments suitable for primary, secondary and tertiary healthcare settings.
    Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2012, Volume: 37, Issue:4

    Topics: Acetic Acid; Administration, Topical; Adult; Analysis of Variance; Anti-Infective Agents; Audiometry

2012

Other Studies

1 other study available for tolnaftate and Chronic Disease

ArticleYear
Clinical examinations with chinofungin spray and chinofungin powder.
    Therapia Hungarica (English edition), 1989, Volume: 37, Issue:1

    Topics: Aerosols; Chronic Disease; Dermatomycoses; Humans; Powders; Tinea Versicolor; Tolnaftate

1989